Page last updated: 2024-11-06

2,6-dimethyl-1,4-benzoquinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2,6-Dimethyl-1,4-benzoquinone, also known as 2,6-dimethylquinone or duroquinone, is a quinone derivative with a bright yellow color and a melting point of 118-120 °C. It is a solid at room temperature and is sparingly soluble in water. It is a potent and selective inhibitor of NADH dehydrogenase, a key enzyme in the electron transport chain. This inhibition leads to the disruption of mitochondrial respiration and oxidative phosphorylation, leading to cellular damage and apoptosis. It is also a known inducer of oxidative stress due to its ability to generate reactive oxygen species. The compound has been studied extensively for its potential applications in medicine, particularly as an anticancer agent. However, its potential toxicity limits its clinical use. It is also investigated for its role in environmental pollution, as it can be generated during the combustion of fossil fuels. It is a potent photosensitizer, and therefore, it has been studied for its potential use in photodynamic therapy, a non-invasive treatment for cancer.'

Cross-References

ID SourceID
PubMed CID68241
CHEMBL ID150643
SCHEMBL ID21463
MeSH IDM0108938

Synonyms (49)

Synonym
p-benzoquinone, 2,6-dimethyl-
ai3-61043
2,6-dimethyl-1,4-quinone
ccris 7151
nsc 17549
einecs 208-420-8
3,5-dimethylbenzoquinone
2,6-dimethylbenzoquinone
p-benzoquinone,6-dimethyl-
2,6-dimethylquinone
2,4-dione, 2,6-dimethyl-
2,6-dimethyl-p-benzoquinone
527-61-7
nsc-17549
2,6-xyloquinone
nsc17549
m-xyloquinone
S00326A ,
2,6-dimethyl-1,4-benzoquinone
inchi=1/c8h8o2/c1-5-3-7(9)4-6(2)8(5)10/h3-4h,1-2h
2,6-dimethylbenzo-1,4-quinone
2,5-cyclohexadiene-1,4-dione, 2,6-dimethyl-
GHL.PD_MITSCHER_LEG0.748
2,6-dimethylbenzoquinone, 99%
CHEMBL150643
2,6-dimethyl-[1,4]benzoquinone
2,6-dimethylcyclohexa-2,5-diene-1,4-dione
D2234
2,6-dimethyl-2,5-cyclohexadiene-1,4-dione
2,6-dimethyl-p-quinone
het5tf8zgo ,
unii-het5tf8zgo
A829238
FT-0610685
FT-0610683
AKOS015890831
3,5-dimethyl-1,4-benzoquinone
SCHEMBL21463
2,6-dimethyl-2,5-cyclohexadien-1,4-dione
J-507499
DTXSID00200664
mfcd00001605
AS-64932
AM9985
Q27279891
D90019
2-amino-n-(2-(2-chlorobenzoyl)-4-nitrophenyl)acetamide hydrochloride
CS-W016532
SY048340
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (20)

Assay IDTitleYearJournalArticle
AID19426HPLC capacity factor (logK)1996Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
In vivo activity and hydrophobicity of cytostatic aziridinyl quinones.
AID224601Efficiency at pBR322 DNA interstand cross-linking at 100 uM1996Journal of medicinal chemistry, Jan-19, Volume: 39, Issue:2
Cross-linking and sequence specific alkylation of DNA BY aziridinylquinones. 1. Quinone methides.
AID1181944Glutathione reactivity at 1 mM in presence of 1 mM glutathione containing PBS and 1 mM EDTA buffer at pH 7.4 assessed as remaining GSH level after 30 mins by spectrophotometry by Ellman's method2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Benzoquinones as inhibitors of botulinum neurotoxin serotype A.
AID1374919Growth inhibition of human OVCAR8 cells after 72 hrs by SRB assay2018Bioorganic & medicinal chemistry letters, 04-15, Volume: 28, Issue:7
The synthesis and evaluation of thymoquinone analogues as anti-ovarian cancer and antimalarial agents.
AID610712Activity of Escherichia coli WrbA2010Bioorganic & medicinal chemistry, May-15, Volume: 18, Issue:10
Photolabile ubiquinone analogues for identification and characterization of quinone binding sites in proteins.
AID1374921Selectivity index, ratio of IC50 for SV-40 immortalized human ovarian epithelial cells to IC50 for human A2780cis cells2018Bioorganic & medicinal chemistry letters, 04-15, Volume: 28, Issue:7
The synthesis and evaluation of thymoquinone analogues as anti-ovarian cancer and antimalarial agents.
AID1181943Glutathione reactivity at 1 mM in presence of 1 mM glutathione containing PBS and 1 mM EDTA buffer at pH 7.4 assessed as remaining GSH level after 10 seconds by spectrophotometry by Ellman's method2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Benzoquinones as inhibitors of botulinum neurotoxin serotype A.
AID1374922Antiplasmodial activity against Plasmodium falciparum Dd2 by SYBR Green I fluorescence assay2018Bioorganic & medicinal chemistry letters, 04-15, Volume: 28, Issue:7
The synthesis and evaluation of thymoquinone analogues as anti-ovarian cancer and antimalarial agents.
AID1374928Growth inhibition of SV-40 immortalized human ovarian epithelial cells after 72 hrs by SRB assay2018Bioorganic & medicinal chemistry letters, 04-15, Volume: 28, Issue:7
The synthesis and evaluation of thymoquinone analogues as anti-ovarian cancer and antimalarial agents.
AID1374927Aqueous solubility of the compound in phosphate buffer at pH 7.4 measured after 24 hrs by HPLC method2018Bioorganic & medicinal chemistry letters, 04-15, Volume: 28, Issue:7
The synthesis and evaluation of thymoquinone analogues as anti-ovarian cancer and antimalarial agents.
AID224600Efficiency at pBR322 DNA interstand cross-linking at 10 uM1996Journal of medicinal chemistry, Jan-19, Volume: 39, Issue:2
Cross-linking and sequence specific alkylation of DNA BY aziridinylquinones. 1. Quinone methides.
AID610713Activity of Bacillus subtilis Succinate-ubiquinone oxidoreductase2010Bioorganic & medicinal chemistry, May-15, Volume: 18, Issue:10
Photolabile ubiquinone analogues for identification and characterization of quinone binding sites in proteins.
AID610714Activity of Rhodobacter capsulatus NADH-ubiquinone oxidoreductase2010Bioorganic & medicinal chemistry, May-15, Volume: 18, Issue:10
Photolabile ubiquinone analogues for identification and characterization of quinone binding sites in proteins.
AID1374918Growth inhibition of human A2780 cells after 72 hrs by SRB assay2018Bioorganic & medicinal chemistry letters, 04-15, Volume: 28, Issue:7
The synthesis and evaluation of thymoquinone analogues as anti-ovarian cancer and antimalarial agents.
AID1181939Inhibition of recombinant Clostridium botulinum neurotoxin serotype A light chain assessed as Kinact to KI ratio at 50 uM after 1.5 hrs by SNAPtide FRET based assay2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Benzoquinones as inhibitors of botulinum neurotoxin serotype A.
AID610725Inhibition of Bacillus subtilis Succinate-ubiquinone oxidoreductase using DMB as substrate2010Bioorganic & medicinal chemistry, May-15, Volume: 18, Issue:10
Photolabile ubiquinone analogues for identification and characterization of quinone binding sites in proteins.
AID1374920Growth inhibition of human A2780cis cells after 72 hrs by SRB assay2018Bioorganic & medicinal chemistry letters, 04-15, Volume: 28, Issue:7
The synthesis and evaluation of thymoquinone analogues as anti-ovarian cancer and antimalarial agents.
AID96156In vitro cytotoxicity against Human Chronic Leukemia K562 cells1996Journal of medicinal chemistry, Jan-19, Volume: 39, Issue:2
Cross-linking and sequence specific alkylation of DNA BY aziridinylquinones. 1. Quinone methides.
AID19838Partition coefficient (logP)1996Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
In vivo activity and hydrophobicity of cytostatic aziridinyl quinones.
AID610718Inhibition of photo labeled detergent solubilized succinate:ubiquinone oxidoreductase activity in Bacillus subtilis measured in dark2010Bioorganic & medicinal chemistry, May-15, Volume: 18, Issue:10
Photolabile ubiquinone analogues for identification and characterization of quinone binding sites in proteins.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.25)18.7374
1990's5 (31.25)18.2507
2000's3 (18.75)29.6817
2010's5 (31.25)24.3611
2020's2 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.55 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]